パッケージングにおけるセカンドソース認定：ボトルキャップやポンプのサプライヤーを安全に切り替える方法

What is packaging second-source qualification?

Packaging second-source qualification is the documented process used to prove that an alternate supplier, manufacturing site and component can consistently meet the product’s approved requirements. It is broader than sample approval. A good sample demonstrates what one small batch can do; qualification shows that the supplier’s drawings, materials, tooling, controls, traceability and production process can keep doing it.

The object being qualified is not merely “a pump.” It is a defined combination of supplier, production site, tool or cavity set, component revision, material system and process. If a supplier sends an approved pump from one plant and later transfers it to another unapproved plant or subcontracts its gasket, the supply system has changed even if the sales item number has not.

This distinction matters because “drop-in replacement” is a conclusion earned through evidence, not a supplier’s marketing description. Procurement can initiate the change, but approval normally needs packaging engineering, quality, operations, formulation or product safety, regulatory affairs where applicable, and the brand owner.

Can you directly replace a discontinued pump or bottle cap?

Usually not. A direct commercial purchase can be made quickly, but using the candidate on saleable product before approval transfers hidden risk to the filling line and market. A 24/410 pump may screw onto a 24/410 bottle yet leak in transit, loosen after thermal cycling, dose differently, fail to prime with the formula, stress-crack the neck, or introduce an incompatible gasket or spring.

A replacement can move through an abbreviated route only when documented change assessment shows that the aspects affecting safety, quality, compliance, consumer use and manufacturability have not changed—or when prior platform evidence genuinely covers the candidate. The approving team should be able to answer all of the following:

• Is the legal manufacturer and actual production site identified?
• Does a revision-controlled drawing define every critical interface, not just the nominal neck size?
• Are product-contact materials, additives, colorants, recycled content, lubricants, adhesives, liners and coatings declared?
• Does the component fit the actual bottle and formula rather than a generic reference container?
• Does it run at the approved filling, capping, crimping, torque and inspection settings?
• Do leakage, actuation, dose, compatibility, stability, transport and decoration results meet predefined criteria?
• Are regulatory files, labels, safety substantiation or customer specifications affected?
• Can the supplier maintain traceability and notify the buyer before future material, site, tool or process changes?

A nine-stage second-supplier qualification and revalidation workflow

Stage 1: contain the supply risk and open formal change control

Confirm the last-buy date, remaining approved inventory, consumption rate, products and markets affected, safety-stock coverage, open orders and tooling ownership. Open a change record with an owner, reason, impacted stock-keeping units, target date and approval functions. Prevent informal mixing of old and new components by assigning distinct item codes or revisions and segregating stock.

Stage 2: reconstruct the approved baseline

Collect the approved drawing, bill of materials, material declarations, color standard, golden samples, retained production samples, incoming-inspection plan, defect limits, torque or crimp settings, filling-line setup, test methods, stability reports, transport results, complaints and deviation history. If the legacy specification says only “24/410 black pump,” it is not adequate for a controlled transfer. Measure the retain samples and convert tacit knowledge into a critical-to-quality specification.

Stage 3: prequalify candidate suppliers

Use a structured request for information before requesting decorative samples. Confirm the real manufacturing site, available capacity, relevant product experience, QMS scope, tooling ownership, component traceability, material controls, subcontracted operations, testing capability, business-continuity plan, lead time and willingness to sign a quality agreement. A trader may be acceptable, but only if the manufacturer and change-control chain remain transparent.

Stage 4: perform a documented gap assessment

Compare old and new drawings, specifications and samples characteristic by characteristic. Classify each difference by its potential effect on seal integrity, formula contact, delivered dose, consumer operation, line efficiency, appearance, compliance and logistics. The assessment should state which previous evidence remains valid, which evidence is invalidated and what new testing closes each gap.

Stage 5: approve engineering samples against the specification

Inspect samples from known production tooling and record the tool and cavity identity. Check dimensions, weight, visual workmanship, color and functional fit. Do not accept hand-finished prototypes as qualification evidence for a high-volume moulding or assembly process. Where a new mould is required, approve the tool through defined trial stages and close dimensional or cosmetic deviations before formula testing.

Stage 6: execute risk-based laboratory and filled-product testing

Test the candidate as a system: candidate closure or pump, intended bottle, real formula, decoration and final pack-out. Include an approved incumbent retain or a well-characterized control when possible. Use predefined methods and pass/fail criteria rather than deciding after seeing the results. Accelerated exposure can help find failure modes, but it should not be presented as a universal mathematical substitute for real-time shelf-life evidence.

Stage 7: run a representative line trial

A laboratory fit test cannot reveal bowl-feeder jams, unstable bottle handling, capper-head wear, cross-threading, dip-tube tangling, torque drift or camera-inspection failures. Use production-intent components, formula, equipment, operators and speed. Record settings, rejects, stops, yield and destructive checks at start, middle and end. If the only way to run the new component is to widen a process window beyond the validated range, the change is not yet a drop-in replacement.

Stage 8: approve through a cross-functional review

Quality should verify that all deviations are closed or formally accepted, regulatory and product-safety owners should assess affected markets, engineering should release the drawing and line settings, and procurement should ensure the contract reflects approved source, site and change-notification duties. Define the effective date, stock transition, label or dossier updates, and whether the sources may be mixed within a production batch.

Stage 9: control initial lots and monitor ongoing performance

Apply enhanced incoming inspection and line checks to a defined number of initial production lots, covering different dates and relevant cavities or assembly lines. “Three lots” is a common company convention, not a universal rule; the number must follow risk, process variability and the evidence available. Trend leakage, torque, pump output, line rejects, complaints and supplier nonconformities, then decide whether normal inspection may resume.

What must be compared for bottles, caps and pumps?

Start with the functions the component must perform, then identify the features and process variables that control those functions. The table below is a practical starting point, not a substitute for a product-specific risk assessment.

For the interface measurements behind finish codes, use Boyu’s plastic bottle neck-finish guide. It explains why a finish name is not a complete fit specification. Pump displacement also needs to be measured with the intended formula; the lotion pump output guide shows how nominal output and actual delivered dose can diverge.

What supplier qualifications and credentials should buyers review?

A certificate is one input, not the qualification decision. Buyers should verify the certificate’s legal entity, site address, scope, standard edition, issue/expiry dates, certification body and accreditation status. ISO itself does not certify companies. More importantly, the audit and quality agreement must cover the process that makes the component.

Corporate and supply-chain identity

• Business licence, legal manufacturer, factory address and export entity
• Manufacturer versus trader status, with disclosure of all critical subcontractors
• Ownership of moulds, drawings and intellectual property; maintenance and replacement responsibility
• Financial and continuity considerations, capacity by line, backup utilities and disaster-recovery plan

Quality system and process control

• Incoming material approval, approved sub-suppliers and prevention of unauthorized resin substitution
• Revision control for drawings, bills of material, work instructions and samples
• Mould-cavity identification, preventive maintenance, process setup and in-process monitoring
• Calibrated measuring equipment and capable test methods
• Lot traceability from resin and purchased parts through assembly, inspection and shipment
• Nonconformance control, root-cause analysis, corrective action, complaint handling and recall support
• Written prior-notification requirements for site, tool, material, formulation, sub-supplier and process changes

Technical and regulatory evidence

• Signed specification and drawing with critical dimensions, tolerances, materials and appearance limits
• Product-contact material declarations, safety data where relevant, restricted-substance declarations and market-specific compliance documents
• Certificate of analysis or conformity tied to each lot; understand whether values are actually tested or copied from a typical-data sheet
• Validation reports, test methods, reference samples and retained samples
• A quality agreement defining responsibilities, change notification, audit rights, records, deviations and escalation

How much revalidation is required?

There is no universal test list or sample size for every cosmetic package. Revalidation should be proportionate to the change and the product risk, but it must cover the evidence invalidated by the change. The useful question is not “Do we repeat everything?” It is “Which previous conclusions depended on the old supplier, material, tool, site or process?”

Boyu’s guides to 化粧品ボトルの試験, パッケージの互換性試験, cosmetic bottle leak methods および packaging drop-test standards provide test-specific detail. The second-source protocol should reference controlled versions of the selected methods rather than repeat generic test names.

How should sample size and lot coverage be chosen?

Avoid one sample count for every characteristic. Destructive leakage tests, variable pump-output measurements, cosmetic inspection and long-term stability answer different questions. Base the plan on defect severity, expected variability, method repeatability, number of mould cavities or assembly lines, confidence needed and whether the result is attribute or variable data. Samples should represent production—not a single carefully selected bag—and should cover relevant cavities and more than one production occasion when lot-to-lot variation matters.

Define the analysis before testing: limits, comparison to the incumbent, treatment of outliers, retest rules and who may approve a deviation. A sample that fails should trigger investigation into the failure mechanism; repeatedly testing new samples until one passes is not qualification.

Which standards and regulations apply?

No single global “packaging second-source qualification standard” dictates an identical workflow for every industry. Requirements come from the marketed product, destination country, customer specification and the organization’s quality system. Use sector-specific frameworks carefully rather than presenting pharmaceutical expectations as universal cosmetic law.

Food-contact packs, child-resistant closures, hazardous chemicals, aerosols and transport of dangerous goods introduce other material, migration, performance or certification requirements. The qualification team should begin with the legal classification of the filled product and intended markets, not with a generic certificate checklist.

What if the original supplier stops immediately?

An emergency may justify a faster decision path, but it does not make an unknown component equivalent. First explore approved options: last-time buy, transfer of owned tooling, approved alternative already used on another SKU, temporary production rescheduling, or a controlled market allocation. If management accepts a temporary alternate, use a formal deviation or emergency change with a defined scope.

A defensible emergency release normally includes:

1. A documented risk assessment and rationale for tests performed or deferred
2. Minimum evidence protecting safety, containment, compatibility and intended function
3. Restricted products, markets, quantities and expiry date for the authorization
4. Enhanced inspection, traceability and retention samples
5. Customer or regulatory notification/approval where required
6. A completion plan for outstanding stability, transport or process evidence
7. Explicit stop criteria and a decision to approve, extend or withdraw the source

Do not conceal the new source under the old item code if doing so destroys traceability. Even when the finished pack looks unchanged, complaints and stability observations must be attributable to the supplier, site, lot and component revision.

Common qualification mistakes—and why they fail

• Buying from a catalog description: nominal diameter, finish and color do not define all functional interfaces.
• Qualifying the sales sample: samples may come from a development tool, another site or a selected lot.
• Reviewing certificates without scope: a valid certificate may cover a different legal entity, address or activity.
• Testing empty packages only: the filled formula can swell seals, extract color, corrode metal, change torque or block a pump.
• Skipping the line trial: lab-conforming parts can still cause feeder, capper, crimper or vision-system failures.
• Using supplier limits without product limits: a broad supplier tolerance may be technically manufacturable but incompatible with the brand’s bottle or process.
• Approving one lot and stopping surveillance: a second source must demonstrate repeatability, not one successful shipment.
• Allowing unnotified sub-supplier changes: a different gasket, liner, masterbatch or spring can alter performance without changing the catalog code.

Second-source approval dossier: a buyer’s checklist

The goal is not to recreate paperwork for its own sake. It is to make the approval decision reproducible: another qualified reviewer should be able to see what changed, why the evidence was sufficient, which limitations remain and how routine supply will be controlled.

よくある質問

Sources and further reading

1. ISO — ISO 9001 quality management systems
2. ISO/IAF Auditing Practices Group — External providers guidance
3. ISO — Certification and conformity assessment
4. ISO 22716:2007 — Cosmetics good manufacturing practices
5. European Union — Regulation (EC) No 1223/2009 on cosmetic products
6. 米国食品医薬品局（FDA） — 2022年化粧品規制近代化法
7. 米国FDA：化粧品GMPガイドライン／査察チェックリスト
8. ISO 15378:2017 — Primary packaging materials for medicinal products
9. ICH Q9(R1) — Quality Risk Management
10. ICH Q10 — Pharmaceutical Quality System
11. 米国FDA — ヒト用医薬品および生物学的製剤の包装用容器・閉鎖システム
12. European Commission — EU GMP Annex 15: Qualification and Validation